SAN DIEGO, CA--(Marketwire - April 14, 2008) - Lpath, Inc. (OTCBB: LPTN), the category leader in therapeutic agents against bioactive lipids, has submitted an investigational new drug (IND) application to the U.S. Food and Drug Administration (FDA) for iSONEP™.
